Mineralys Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020
Net Income	-71.9	-29.8	-19.41	-3.43
Share-Based Compensation	5.06	0.46	0.08	0
Other Operating Activities	-14.34	0.12	4.77	0.96
Operating Cash Flow	-81.17	-29.22	-14.56	-2.46
Change in Investments	-160.47	-21.76	0	0
Investing Cash Flow	-160.47	-21.76	0	0
Share Issuance / Repurchase	203.25	-1.63	0	0
Debt Issued / Paid	0	0	0	3.85
Other Financing Activities	-	129.65	23.81	-0.02
Financing Cash Flow	203.25	128.02	23.81	3.83
Net Cash Flow	-38.4	77.04	9.25	1.37
Free Cash Flow	-81.17	-29.22	-14.56	-2.46
Free Cash Flow Per Share	-2.24	-5.66	-2.92	-0.05

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).